```html

Kurtz Disease (Subacute Osteomyelitis) – A Patient‑Friendly Medical Guide

Overview

Kurtz disease, more commonly called subacute osteomyelitis, is a bone infection that develops more slowly than the acute form. It usually follows an initial infection (often an acute osteomyelitis that was partially treated) or spreads from a nearby focus such as a skin wound, dental infection, or hematogenous (blood‑borne) source.

• Who it affects: It can occur at any age, but peaks in two groups – children 5‑15 years old and adults 40‑70 years old.
• Prevalence: Osteomyelitis overall accounts for about 1‑2 % of all bone‐related hospital admissions in the United States (CDC). Subacute cases represent roughly 15‑30 % of those infections, making the condition relatively rare but clinically important.
• Key points: The infection is usually caused by Staphylococcus aureus (including methicillin‑resistant strains), but other bacteria or, rarely, fungi can be involved.

Symptoms

Because the infection progresses slowly, symptoms can be subtle and may wax and wane over weeks to months. Common manifestations include:

Pain

• Deep, throbbing or aching pain localized to the affected bone.
• Pain may worsen at night or with weight‑bearing activity.
• Sometimes the pain is intermittent, leading patients to delay medical care.

Localized Swelling & Tenderness

• Soft‑tissue swelling over the bone.
• Warmth or reddening may be mild compared with acute infection.

Fever & Systemic Signs

• Low‑grade fever (often <38 °C/100.4 °F) or occasional spikes.
• General fatigue, malaise, or mild chills.

Reduced Function

• Difficulty using the affected limb or joint.
• Limiting activities such as walking, climbing stairs, or gripping.

Other Possible Findings

• Sinus tract or purulent drainage in chronic‑evolving cases.
• Weight loss or night sweats (more common in immunocompromised patients).
• History of recent trauma, surgery, or a lingering wound near the bone.

Causes and Risk Factors

Primary Causes

• Staphylococcus aureus – the most frequent organism (≈70 %).
• Other bacteria: Streptococcus pyogenes, Enterobacteriaceae, Pseudomonas aeruginosa (especially in foot ulcers), and Mycobacterium tuberculosis (rare, “tuberculous osteomyelitis”).
• Fungal pathogens (e.g., Candida spp.) in immunosuppressed hosts.

How the Infection Starts

1. Hematogenous spread – bacteria travel through the bloodstream from another site (e.g., skin infection, urinary tract infection).
2. Direct inoculation – after an open fracture, surgical implant, or puncture wound.
3. Contiguous spread – infection spreads from an adjacent soft‑tissue infection or sinus.

Risk Factors

• Recent trauma or orthopedic surgery (especially with implants).
• Chronic skin ulcers, especially in the foot (diabetic patients).
• Immunosuppression – Diabetes mellitus, HIV/AIDS, chemotherapy, chronic steroid use.
• Peripheral vascular disease, which impairs blood flow to bone.
• People with sickle‑cell disease or other hemoglobinopathies (higher risk of Salmonella osteomyelitis).
• Age extremes (young children and older adults) due to differing immune responses.

Diagnosis

Diagnosing subacute osteomyelitis requires a combination of clinical suspicion, laboratory tests, and imaging. Because symptoms can be mild, physicians often need a systematic approach.

Medical History & Physical Examination

• Detail of recent injuries, surgeries, or infections.
• Assessment of pain pattern, swelling, and any draining sinus.

Laboratory Tests

Test	Typical Findings in Subacute Osteomyelitis
Complete Blood Count (CBC)	Mild leukocytosis or normal.
Erythrocyte Sedimentation Rate (ESR)	Elevated (often 30‑70 mm/hr).
C‑reactive Protein (CRP)	Modestly raised (10‑40 mg/L).
Blood cultures	Positive in ≈30 % of cases; more likely if bacteremia present.

Imaging Studies

• Plain Radiographs (X‑ray) – May show periosteal reaction, lucent lesions, or sclerosis after 2‑3 weeks.
• Magnetic Resonance Imaging (MRI) – Gold standard for early detection; shows bone marrow edema, soft‑tissue involvement, and can guide surgical planning.
• Computed Tomography (CT) – Helpful for evaluating cortical bone destruction and for surgical navigation.
• Bone Scan (Technetium‑99m) – Highly sensitive; highlights increased osteoblastic activity but less specific.
• Ultrasound – Useful for detecting adjacent soft‑tissue abscesses, especially in children.

Microbiological Confirmation

• Percutaneous needle biopsy (CT‑guided) or open surgical biopsy for culture & histopathology.
• Obtaining a specimen is essential when the organism is unclear or when MRSA is suspected.

Diagnostic Criteria (Simplified)

Most experts consider a case subacute when all of the following are present:

1. Symptoms lasting >2 weeks but < 6 weeks.
2. Moderate elevation of ESR/CRP without high fever.
3. Imaging evidence of bone infection.
4. Positive microbiology (cultures) or a strong clinical‑radiographic correlation.

Treatment Options

Management aims to eradicate the infection, preserve bone integrity, and restore function. Treatment is usually a combination of antibiotics and, when needed, surgical intervention.

Antibiotic Therapy

• Empiric Regimen (initial 48‑72 h) – Usually a combination covering MRSA and gram‑negative organisms, such as vancomycin + ceftriaxone or a carbapenem.
• Targeted Therapy – Adjusted once culture results are available. Common options:
  • MRSA: Vancomycin, Daptomycin, or Linezolid.
  • MSSA: Nafcillin or Oxacillin.
  • Gram‑negative: Cefepime, Piperacillin‑tazobactam, or a fluoroquinolone (if susceptible).
• Duration – Typically 4‑6 weeks of intravenous (IV) therapy, followed by 2‑4 weeks of oral antibiotics if clinical response is good and inflammatory markers trend down.
• Oral agents with excellent bone penetration (e.g., clindamycin, fluoroquinolones, rifampin for staphylococcal infections) may be used after the IV phase.

Surgical Management

Surgery is indicated when there is:

• Abscess or sequestrum (dead bone) that cannot be cleared by antibiotics alone.
• Failure to improve after 7‑10 days of appropriate antibiotics.
• Implant‑related infection requiring debridement or hardware removal.

Procedures include:

• Incision & Drainage (I&D) – Removes pus and reduces pressure.
• Sequestrectomy – Excision of dead bone.
• Debridement with bone grafting or cement spacers – Restores structural stability.
• Negative pressure wound therapy (NPWT) – Helps close large soft‑tissue defects.

Adjunctive Therapies & Lifestyle Measures

• Optimizing blood glucose in diabetics.
• Smoking cessation – improves bone healing.
• Physical therapy once infection is controlled to maintain joint range of motion.
• Pain control with acetaminophen or NSAIDs (unless contraindicated).

Living with Kurtz Disease (Subacute Osteomyelitis)

Managing day‑to‑day life while undergoing treatment can be challenging. Below are practical tips to help patients stay comfortable and promote healing.

Medication Adherence

• Use a pill organizer or a medication‑reminder app.
• Never stop antibiotics early, even if you feel better, unless your doctor tells you to.
• Report side effects promptly (e.g., rash, kidney problems, hearing changes).

Wound & Skin Care

• Keep any surgical incisions clean and dry; follow dressing change instructions.
• Inspect the area daily for increased redness, drainage, or foul odor.

Activity & Mobility

• Follow weight‑bearing restrictions given by your surgeon—often “partial weight‑bearing” for 4‑6 weeks.
• Use assistive devices (crutches, walker) as needed to prevent falls.
• Gentle range‑of‑motion exercises are usually allowed; avoid high‑impact sports until cleared.

Nutrition

• Aim for 1.2–1.5 g protein/kg body weight daily to support bone repair.
• Consume foods rich in calcium and vitamin D (dairy, fortified plant milks, fatty fish).
• Stay well‑hydrated; adequate fluids support kidney function during IV antibiotics.

Monitoring & Follow‑up

• Schedule regular blood tests (CBC, ESR, CRP, renal function) as ordered.
• Attend all imaging appointments; repeat MRI may be needed if symptoms persist.
• Keep a symptom diary noting pain level, fever spikes, and any new swelling.

Prevention

While not all cases can be avoided, several measures can significantly reduce risk.

• Prompt treatment of skin and soft‑tissue infections – especially in diabetics or those with peripheral vascular disease.
• Proper wound care after injuries or surgeries; follow sterile technique and keep dressings intact.
• Vaccinations – e.g., influenza and pneumococcal vaccines lower the chance of bacteremia that could seed bone.
• Manage chronic illnesses – optimal glucose control, regular dental check‑ups, and tobacco cessation.
• Protect high‑risk bones – Use protective gear during contact sports; avoid repetitive micro‑trauma (e.g., overuse in athletes).

Complications

If left untreated or incompletely treated, subacute osteomyelitis can lead to serious sequelae:

• Chronic osteomyelitis – Persistent infection with sinus tract formation; may require multiple surgeries.
• Sequestrum formation – Dead bone that can act as a nidus for recurrent infection.
• Pathologic fracture – Weakening of the bone increases fracture risk, especially in weight‑bearing sites.
• Growth plate damage in children – Can cause limb length discrepancy or angular deformities.
• Systemic spread – Rarely, infection can spread to the bloodstream (septicemia) or adjacent joints, causing septic arthritis.
• Amputation – In extreme, uncontrolled cases, especially with peripheral artery disease, loss of limb may be necessary.

When to Seek Emergency Care

References

• Mayo Clinic. “Osteomyelitis.” Updated 2023. https://www.mayoclinic.org
• Centers for Disease Control and Prevention (CDC). “Bone and Joint Infections.” 2022. https://www.cdc.gov
• National Institutes of Health (NIH) – National Library of Medicine. “Subacute osteomyelitis.” 2021. https://www.ncbi.nlm.nih.gov
• Cleveland Clinic. “Osteomyelitis Treatment Options.” 2023. https://my.clevelandclinic.org
• World Health Organization (WHO). “Antimicrobial resistance (AMR).” 2022. https://www.who.int
• Flørenes VA, et al. “Management of subacute and chronic osteomyelitis.” *Journal of Bone & Joint Surgery* (American) 2020;102(9):810‑819.

```